Breast Cancer
This session provides
a focused exploration of advancements in breast cancer
screening, diagnostics, and targeted therapies. It will discuss molecular
classification, genetic risk assessment, and subtype-specific treatment
protocols. Special attention will be given to innovations in imaging,
reconstructive surgery, and novel systemic treatments like CDK4/6 inhibitors.
Experts will examine patient-centred approaches, survivorship care, and quality
of life considerations. Recent clinical trial outcomes and evolving global
trends will also be reviewed.
Subtracks:
- Triple-Negative Breast Cancer Advances
- HER2-Targeted Therapies
- Breast Imaging Innovations
- Genetic Risk Assessment & BRCA Mutation Studies
- Breast-Conserving and Reconstructive Surgery
- Survivorship and Quality of Life